Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does iron deficiency impair immune cell function and promote dysregulated inflammation?

Iron deficiency compromises immune cell proliferation and mitochondrial metabolism and is associated with increased systemic inflammatory markers.

SupportedJune 19, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Iron deficiency can impair immune cell function and is associated with dysregulated inflammatory responses.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that low iron limits essential enzymatic and metabolic processes in both adaptive and innate immune cells, reducing T‑ and B‑cell proliferation and impairing macrophage/NK cell activation. It also frames a bidirectional hepcidin–IL‑6 cycle linking iron restriction to chronic low‑grade inflammation, reflected by elevated biomarkers such as hs‑CRP and proinflammatory cytokines.

Verified conclusion

Iron is a fundamental nutrient for the immune system, serving as an essential cofactor for metabolic and enzymatic processes that govern both innate and adaptive immune responses. Deficiencies in iron status, regardless of whether anemia is present, lead to quantifiable impairments in immune cell proliferation and the regulation of systemic inflammation.

Mechanisms of immune impairment

Iron is vital for the metabolic health of immune cells, particularly through its role in DNA synthesis and energy production:

  • Adaptive immunity: T-cell and B-cell proliferation depends on ribonucleotide reductase (RNR), an iron-dependent enzyme that catalyzes the rate-limiting step of DNA synthesis. Iron deficiency disrupts this process and impairs histone demethylases (like KDM2B), which are required for cell cycle progression (S-phase entry).
  • Innate immunity: Iron is a central component of the mitochondrial electron transport chain. Low iron availability suppresses oxidative phosphorylation (OXPHOS), which prevents the proper activation and polarization of macrophages and natural killer (NK) cells.
  • Clinical consequences: These cellular deficits often translate to a 3- to 4-fold increased risk of infection and diminished antibody production following vaccination.

Dysregulated inflammatory responses

Iron deficiency is strongly associated with a state of chronic, low-grade inflammation, often characterized by elevated biomarkers such as high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6):

  • The Hepcidin Axis: Inflammation triggers the production of hepcidin, which sequesters iron within macrophages. Conversely, low systemic iron can sustain inflammatory signaling, creating a bidirectional cycle where iron restriction and systemic inflammation reinforce one another.
  • Biomarker evidence: Research indicates that individuals with iron deficiency anemia exhibit significantly higher plasma levels of TNF-α and IL-6 compared to healthy controls. Interventions such as iron supplementation have been shown to reduce these inflammatory markers while restoring iron parameters.

Bottom line

Iron deficiency directly impairs immune cell function by stalling DNA synthesis and mitochondrial metabolism, while simultaneously promoting dysregulated systemic inflammation through the hepcidin-IL-6 axis. Addressing iron status is critical for maintaining robust immune defenses and regulating the inflammatory response.

References

  1. Adaptive immunity and vaccination – iron in the spotlight — academic.oup.com ↗
  2. Iron Metabolism and Immune Regulation — pmc.ncbi.nlm.nih.gov ↗
  3. Cutting Edge: Activation-Induced Iron Flux Controls CD4 T Cell Proliferation by Promoting Proper IL-2R Signaling and Mitochondrial Function — pmc.ncbi.nlm.nih.gov ↗
  4. Analysis of Iron and Iron-Interacting Protein Dynamics During T-Cell Activation — pmc.ncbi.nlm.nih.gov ↗
  5. Decoding iron deficiency in cancer: mechanisms, immune modulation, and therapeutic potential — frontiersin.org ↗
  6. Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses — nature.com ↗
  7. Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trial — pmc.ncbi.nlm.nih.gov ↗
  8. Iron homeostasis and the inflammatory response. — pmc.ncbi.nlm.nih.gov ↗
  9. Changes in pro-inflammatory cytokines and antimicrobial proteins in elderly women with iron deficiency anemia — pjms.org.pk ↗
  10. Iron in immune cell function and host defense. — linkinghub.elsevier.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→